BTIG Downgrades Ginkgo Bioworks Holdings to Neutral
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Mark Massaro has downgraded Ginkgo Bioworks Holdings (NYSE:DNA) from Buy to Neutral.
November 09, 2023 | 2:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings has been downgraded from Buy to Neutral by BTIG analyst Mark Massaro.
The downgrade from Buy to Neutral by BTIG analyst Mark Massaro indicates a less optimistic outlook for Ginkgo Bioworks Holdings. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100